0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Othe-3142
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Vaccines Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Othe-3142
Report
July 2021
121 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Vaccines Market Statistics 2027

In 2020, the global Vaccines market size was US$ 42560 million and it is expected to reach US$ 62780 million by the end of 2027, with a CAGR of 5.6% during 2021-2027. Due to a growth in the prevalence of both viral and bacterial infectious diseases, the vaccine market is predicted to grow. Furthermore, as people become more aware of early disease identification and prevention, demand for protective vaccines increases, propelling the vaccine industry forward. Furthermore, greater investment in the discovery of innovative vaccines is expected to fuel the global vaccines market in the coming years.
Vaccines Market

Trends Influencing The Growth of Vaccines Market Size

Governments and pharmaceutical corporations are investing extensively in vaccine development in response to the increased prevalence of infectious diseases such as HIV, hepatitis, and tuberculosis. For example, the COVID pandemic has led to over 80 million cases worldwide, and several businesses have treatments in development to treat the disease, fueling the vaccine market in the coming years. In addition, most countries are aiming to flatten the community transmission curve, which is increasing immunization demand. In addition, the prevalence of infectious diseases such as malaria and influenza is increasing, which is raising income.
Vaccines Market Size
 

Due to increased awareness of the benefits of vaccination, improved understanding of pathogen biology and the human immune system, and more favorable legislation controlling vaccine damage compensation, vaccine production has become more desirable. The development of vaccines for new indications with high unmet demand has also been aided by novel vaccine manufacturing and adjuvant technologies. Vaccines, which have a much higher entry barrier than generic copies of branded treatments, are becoming more commercially viable as large pharmaceutical corporations suffer big revenue losses as a result of generic versions of branded drugs. This in turn is expected to drive the growth of the vaccine market.

Furthermore, the vaccine market is predicted to expand due to the increased need for new medications to replace ones that have lost their efficacy, as well as an increase in the number of vaccination clinical trials. On the other side, rigorous regulations and expensive vaccine costs are impeding the vaccine market's growth. A lack of understanding of some vaccines, cost-prohibited vaccinations in third-world countries, and restricted availability and affordability will all stymie the vaccine business.

Top Companies in Vaccines Market 

The major players in the global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market.

Vaccines Market Share Analysis

The primary markets are North America and Europe, which account for around 65 percent of the global market. This is due to rising vaccination demand among adults and children, increased government immunization efforts, and the majority of vaccinations accessible in the United States.

Recombinant Vaccines are predicted to have the greatest share of the market, accounting for around 35%. The recombinant vaccines market is being driven by increased technical advanced devices, an increasing number of regulatory approvals, a higher incidence of infectious diseases, and growing penetration of key market participants.

According to the application, HPV had the greatest percentage of almost 35%. The market is predicted to grow as the incidence of HPV-related diseases such as anal, oropharyngeal, and genital cancers rises, as well as demand for HPV vaccines to help prevent infections.

Vaccines Market By Type

  • Recombinant Vaccines
  • Viral Vaccines
  • Polysaccharide Vaccines
  • Others

Vaccines Market By Application

  • Rabies vaccine
  • Influenza vaccine
  • HPV vaccine
  • Hepatitis B
  • Hepatitis A
  • Leprosy vaccine
  • Polio vaccine
  • JE vaccine
  • Others

Vaccines Market By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
  • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Vaccines Market Share Analysis

Vaccines market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Vaccines product introduction, recent developments, Vaccines sales by region, type, application and by sales channel. 

Vaccines Market By Company

  • GSK
  • Sanofi
  • Merck
  • Pfizer
  • Novartis(GSK)
  • CSL
  • MedImmune LLC
  • J&J(Crucell)
  • China National Biotec
  • Tiantan
  • Hualan
  • Kangtai
  • Hissen
  • Jintan

Vaccines Market Scope

Report Metric

Details

Report Name

Vaccines Market

The Market size value in 2020

42560 Million USD

The Revenue forecast in 2027

62780 Million USD

Growth Rate

CAGR of 5.6% from 2021 to 2027

Base year considered

2020

Forecast period

2021- 2027

Forecast units

Value (USD)

Segments covered

Type, End-User, Offerings, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Companies covered

GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell), China National Biotec, Tiantan, Hualan, Kangtai, Hissen, Jintan.

Frequently Asked Questions About This Report

1.How Big is the Vaccines Market?

Ans. In 2020, the global Vaccines market size was US$ 42560 million and it is expected to reach US$ 62780 million by the end of 2027.

2. What is the Vaccines Market Growth?

Ans. The global Vaccines market is expected to grow at a compound annual growth rate of 5.6% from 2021 to 2027.

3. Who are the major key players in Vaccines Market?

Ans. GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell), China National Biotec, Tiantan, Hualan, Kangtai, Hissen, Jintan.

1 Study Coverage
1.1 Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Vaccines Market Size Growth Rate by Type
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaccines Market Size Growth Rate by Application
1.3.2 Rabies vaccine
1.3.3 Influenza vaccine
1.3.4 HPV vaccine
1.3.5 Hepatitis B
1.3.6 Hepatitis A
1.3.7 Leprosy vaccine
1.3.8 Polio vaccine
1.3.9 JE vaccine
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccines Market Size Estimates and Forecasts
2.1.1 Global Vaccines Revenue 2016-2027
2.1.2 Global Vaccines Sales 2016-2027
2.2 Vaccines Market Size by Region: 2021 Versus 2027
2.3 Vaccines Sales by Region (2016-2027)
2.3.1 Global Vaccines Sales by Region: 2016-2021
2.3.2 Global Vaccines Sales Forecast by Region (2022-2027)
2.3.3 Global Vaccines Sales Market Share by Region (2016-2027)
2.4 Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Vaccines Revenue by Region: 2016-2021
2.4.2 Global Vaccines Revenue Forecast by Region (2022-2027)
2.4.3 Global Vaccines Revenue Market Share by Region (2016-2027)
3 Global Vaccines by Manufacturers
3.1 Global Top Vaccines Manufacturers by Sales
3.1.1 Global Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Vaccines Manufacturers by Revenue
3.2.1 Global Vaccines Revenue by Manufacturer (2016-2021)
3.2.2 Global Vaccines Revenue Share by Manufacturer (2016-2021)
3.3 Global Vaccines Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Vaccines Manufacturers Covered: Ranking by Revenue
3.4.2 Global Vaccines Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Vaccines Manufacturing Base Distribution, Product Type
3.5.1 Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Vaccines Product Type
3.5.3 Date of International Manufacturers Enter into Vaccines Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 GSK
4.1.1 GSK Corporation Information
4.1.2 GSK Description, Business Overview
4.1.3 GSK Vaccines Products Offered
4.1.4 GSK Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.1.5 GSK Vaccines Revenue by Product
4.1.6 GSK Vaccines Revenue by Application
4.1.7 GSK Vaccines Revenue by Geographic Area
4.1.8 GSK Vaccines Revenue by Sales Channel
4.1.9 GSK Recent Development
4.2 Sanofi
4.2.1 Sanofi Corporation Information
4.2.2 Sanofi Description, Business Overview
4.2.3 Sanofi Vaccines Products Offered
4.2.4 Sanofi Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Sanofi Vaccines Revenue by Product
4.2.6 Sanofi Vaccines Revenue by Application
4.2.7 Sanofi Vaccines Revenue by Geographic Area
4.2.8 Sanofi Vaccines Revenue by Sales Channel
4.2.9 Sanofi Recent Development
4.3 Merck
4.3.1 Merck Corporation Information
4.3.2 Merck Description, Business Overview
4.3.3 Merck Vaccines Products Offered
4.3.4 Merck Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Merck Vaccines Revenue by Product
4.3.6 Merck Vaccines Revenue by Application
4.3.7 Merck Vaccines Revenue by Geographic Area
4.3.8 Merck Vaccines Revenue by Sales Channel
4.3.9 Merck Recent Development
4.4 Pfizer
4.4.1 Pfizer Corporation Information
4.4.2 Pfizer Description, Business Overview
4.4.3 Pfizer Vaccines Products Offered
4.4.4 Pfizer Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Pfizer Vaccines Revenue by Product
4.4.6 Pfizer Vaccines Revenue by Application
4.4.7 Pfizer Vaccines Revenue by Geographic Area
4.4.8 Pfizer Vaccines Revenue by Sales Channel
4.4.9 Pfizer Recent Development
4.5 Novartis(GSK)
4.5.1 Novartis(GSK) Corporation Information
4.5.2 Novartis(GSK) Description, Business Overview
4.5.3 Novartis(GSK) Vaccines Products Offered
4.5.4 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Novartis(GSK) Vaccines Revenue by Product
4.5.6 Novartis(GSK) Vaccines Revenue by Application
4.5.7 Novartis(GSK) Vaccines Revenue by Geographic Area
4.5.8 Novartis(GSK) Vaccines Revenue by Sales Channel
4.5.9 Novartis(GSK) Recent Development
4.6 CSL
4.6.1 CSL Corporation Information
4.6.2 CSL Description, Business Overview
4.6.3 CSL Vaccines Products Offered
4.6.4 CSL Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.6.5 CSL Vaccines Revenue by Product
4.6.6 CSL Vaccines Revenue by Application
4.6.7 CSL Vaccines Revenue by Geographic Area
4.6.8 CSL Recent Development
4.7 MedImmune LLC
4.7.1 MedImmune LLC Corporation Information
4.7.2 MedImmune LLC Description, Business Overview
4.7.3 MedImmune LLC Vaccines Products Offered
4.7.4 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.7.5 MedImmune LLC Vaccines Revenue by Product
4.7.6 MedImmune LLC Vaccines Revenue by Application
4.7.7 MedImmune LLC Vaccines Revenue by Geographic Area
4.7.8 MedImmune LLC Recent Development
4.8 J&J(Crucell)
4.8.1 J&J(Crucell) Corporation Information
4.8.2 J&J(Crucell) Description, Business Overview
4.8.3 J&J(Crucell) Vaccines Products Offered
4.8.4 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.8.5 J&J(Crucell) Vaccines Revenue by Product
4.8.6 J&J(Crucell) Vaccines Revenue by Application
4.8.7 J&J(Crucell) Vaccines Revenue by Geographic Area
4.8.8 J&J(Crucell) Recent Development
4.9 China National Biotec
4.9.1 China National Biotec Corporation Information
4.9.2 China National Biotec Description, Business Overview
4.9.3 China National Biotec Vaccines Products Offered
4.9.4 China National Biotec Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.9.5 China National Biotec Vaccines Revenue by Product
4.9.6 China National Biotec Vaccines Revenue by Application
4.9.7 China National Biotec Vaccines Revenue by Geographic Area
4.9.8 China National Biotec Recent Development
4.10 Tiantan
4.10.1 Tiantan Corporation Information
4.10.2 Tiantan Description, Business Overview
4.10.3 Tiantan Vaccines Products Offered
4.10.4 Tiantan Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Tiantan Vaccines Revenue by Product
4.10.6 Tiantan Vaccines Revenue by Application
4.10.7 Tiantan Vaccines Revenue by Geographic Area
4.10.8 Tiantan Recent Development
4.11 Hualan
4.11.1 Hualan Corporation Information
4.11.2 Hualan Description, Business Overview
4.11.3 Hualan Vaccines Products Offered
4.11.4 Hualan Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Hualan Vaccines Revenue by Product
4.11.6 Hualan Vaccines Revenue by Application
4.11.7 Hualan Vaccines Revenue by Geographic Area
4.11.8 Hualan Recent Development
4.12 Kangtai
4.12.1 Kangtai Corporation Information
4.12.2 Kangtai Description, Business Overview
4.12.3 Kangtai Vaccines Products Offered
4.12.4 Kangtai Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.12.5 Kangtai Vaccines Revenue by Product
4.12.6 Kangtai Vaccines Revenue by Application
4.12.7 Kangtai Vaccines Revenue by Geographic Area
4.12.8 Kangtai Recent Development
4.13 Hissen
4.13.1 Hissen Corporation Information
4.13.2 Hissen Description, Business Overview
4.13.3 Hissen Vaccines Products Offered
4.13.4 Hissen Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.13.5 Hissen Vaccines Revenue by Product
4.13.6 Hissen Vaccines Revenue by Application
4.13.7 Hissen Vaccines Revenue by Geographic Area
4.13.8 Hissen Recent Development
4.14 Jintan
4.14.1 Jintan Corporation Information
4.14.2 Jintan Description, Business Overview
4.14.3 Jintan Vaccines Products Offered
4.14.4 Jintan Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.14.5 Jintan Vaccines Revenue by Product
4.14.6 Jintan Vaccines Revenue by Application
4.14.7 Jintan Vaccines Revenue by Geographic Area
4.14.8 Jintan Recent Development
5 Breakdown Data by Type
5.1 Global Vaccines Sales by Type (2016-2027)
5.1.1 Global Vaccines Sales by Type (2016-2021)
5.1.2 Global Vaccines Sales Forecast by Type (2022-2027)
5.1.3 Global Vaccines Sales Market Share by Type (2016-2027)
5.2 Global Vaccines Revenue Forecast by Type (2016-2027)
5.2.1 Global Vaccines Revenue by Type (2016-2021)
5.2.2 Global Vaccines Revenue Forecast by Type (2022-2027)
5.2.3 Global Vaccines Revenue Market Share by Type (2016-2027)
5.3 Vaccines Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Vaccines Sales by Application (2016-2027)
6.1.1 Global Vaccines Sales by Application (2016-2021)
6.1.2 Global Vaccines Sales Forecast by Application (2022-2027)
6.1.3 Global Vaccines Sales Market Share by Application (2016-2027)
6.2 Global Vaccines Revenue Forecast by Application (2016-2027)
6.2.1 Global Vaccines Revenue by Application (2016-2021)
6.2.2 Global Vaccines Revenue Forecast by Application (2022-2027)
6.2.3 Global Vaccines Revenue Market Share by Application (2016-2027)
6.3 Vaccines Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Vaccines Market Size YoY Growth 2016-2027
7.2 North America Vaccines Market Facts & Figures by Country
7.2.1 North America Vaccines Sales by Country (2016-2027)
7.2.2 North America Vaccines Revenue by Country (2016-2027)
7.3 North America Vaccines Sales by Type
7.4 North America Vaccines Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Vaccines Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Vaccines Market Facts & Figures by Region
8.2.1 Asia-Pacific Vaccines Sales by Region (2016-2027)
8.2.2 Asia-Pacific Vaccines Revenue by Region (2016-2027)
8.3 Asia-Pacific Vaccines Sales by Type
8.4 Asia-Pacific Vaccines Sales by Application
9 Europe
9.1 Europe Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Vaccines Market Facts & Figures by Country
9.2.1 Europe Vaccines Sales by Country (2016-2027)
9.2.2 Europe Vaccines Revenue by Country (2016-2027)
9.3 Europe Vaccines Sales by Type
9.4 Europe Vaccines Sales by Application
10 Latin America
10.1 Latin America Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Vaccines Market Facts & Figures by Country
10.2.1 Latin America Vaccines Sales by Country (2016-2027)
10.2.2 Latin America Vaccines Revenue by Country (2016-2027)
10.3 Latin America Vaccines Sales by Type
10.4 Latin America Vaccines Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Vaccines Sales by Country (2016-2027)
11.2.2 Middle East and Africa Vaccines Revenue by Country (2016-2027)
11.3 Middle East and Africa Vaccines Sales by Type
11.4 Middle East and Africa Vaccines Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Vaccines Supply Chain Analysis
12.2 Vaccines Key Raw Materials and Upstream Suppliers
12.3 Vaccines Clients Analysis
12.4 Vaccines Sales Channel and Sales Model Analysis
12.4.1 Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Vaccines Distributors
13 Market Dynamics
13.1 Vaccines Market Drivers
13.2 Vaccines Market Opportunities
13.3 Vaccines Market Challenges
13.4 Vaccines Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Vaccines Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Recombinant Vaccines
    Table 3. Major Manufacturers of Viral Vaccines
    Table 4. Major Manufacturers of Polysaccharide Vaccines
    Table 5. Major Manufacturers of Others
    Table 6. Global Vaccines Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 7. Global Vaccines Market Size by Region (US$ Million): 2021 VS 2027
    Table 8. Global Vaccines Sales by Region (2016-2021) & (K Pcs)
    Table 9. Global Vaccines Sales Forecast by Region (2022-2027) & (K Pcs)
    Table 10. Global Vaccines Revenue by Region (2016-2021) & (US$ Million)
    Table 11. Global Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Vaccines Sales by Manufacturer (2016-2021) & (K Pcs)
    Table 13. Global Vaccines Sales Share by Manufacturer (2016-2021)
    Table 14. Vaccines Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 15. Vaccines Revenue Share by Manufacturer (2016-2021)
    Table 16. Key Manufacturers Vaccines Price (2016-2021) & (US$/Pcs)
    Table 17. Ranking of Global Top Vaccines Manufacturers by Revenue (US$ Million) in 2020
    Table 18. Global Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccines as of 2020)
    Table 20. Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
    Table 21. Manufacturers Vaccines Product Type
    Table 22. Date of International Manufacturers Enter into Vaccines Market
    Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 24. GSK Corporation Information
    Table 25. GSK Description and Business Overview
    Table 26. GSK Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 27. GSK Vaccines Product
    Table 28. GSK Vaccines Revenue (US$ Million) and Market Share by Product
    Table 29. GSK Vaccines Revenue (US$ Million) and Market Share by Application
    Table 30. GSK Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 31. GSK Vaccines Revenue (US$ Million) and Market Share by Sales Channel
    Table 32. GSK Recent Development
    Table 33. Sanofi Corporation Information
    Table 34. Sanofi Description and Business Overview
    Table 35. Sanofi Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 36. Sanofi Vaccines Product
    Table 37. Sanofi Vaccines Revenue (US$ Million) and Market Share by Product
    Table 38. Sanofi Vaccines Revenue (US$ Million) and Market Share by Application
    Table 39. Sanofi Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 40. Sanofi Vaccines Revenue (US$ Million) and Market Share by Sales Channel
    Table 41. Sanofi Recent Development
    Table 42. Merck Corporation Information
    Table 43. Merck Description and Business Overview
    Table 44. Merck Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 45. Merck Vaccines Product
    Table 46. Merck Vaccines Revenue (US$ Million) and Market Share by Product
    Table 47. Merck Vaccines Revenue (US$ Million) and Market Share by Application
    Table 48. Merck Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 49. Merck Vaccines Revenue (US$ Million) and Market Share by Sales Channel
    Table 50. Merck Recent Development
    Table 51. Pfizer Corporation Information
    Table 52. Pfizer Description and Business Overview
    Table 53. Pfizer Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 54. Pfizer Vaccines Product
    Table 55. Pfizer Vaccines Revenue (US$ Million) and Market Share by Product
    Table 56. Pfizer Vaccines Revenue (US$ Million) and Market Share by Application
    Table 57. Pfizer Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 58. Pfizer Vaccines Revenue (US$ Million) and Market Share by Sales Channel
    Table 59. Pfizer Recent Development
    Table 60. Novartis(GSK) Corporation Information
    Table 61. Novartis(GSK) Description and Business Overview
    Table 62. Novartis(GSK) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 63. Novartis(GSK) Vaccines Product
    Table 64. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Product
    Table 65. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Application
    Table 66. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 67. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Sales Channel
    Table 68. Novartis(GSK) Recent Development
    Table 69. CSL Corporation Information
    Table 70. CSL Description and Business Overview
    Table 71. CSL Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 72. CSL Vaccines Product
    Table 73. CSL Vaccines Revenue (US$ Million) and Market Share by Product
    Table 74. CSL Vaccines Revenue (US$ Million) and Market Share by Application
    Table 75. CSL Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 76. CSL Recent Development
    Table 77. MedImmune LLC Corporation Information
    Table 78. MedImmune LLC Description and Business Overview
    Table 79. MedImmune LLC Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 80. MedImmune LLC Vaccines Product
    Table 81. MedImmune LLC Vaccines Revenue (US$ Million) and Market Share by Product
    Table 82. MedImmune LLC Vaccines Revenue (US$ Million) and Market Share by Application
    Table 83. MedImmune LLC Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 84. MedImmune LLC Recent Development
    Table 85. J&J(Crucell) Corporation Information
    Table 86. J&J(Crucell) Description and Business Overview
    Table 87. J&J(Crucell) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 88. J&J(Crucell) Vaccines Product
    Table 89. J&J(Crucell) Vaccines Revenue (US$ Million) and Market Share by Product
    Table 90. J&J(Crucell) Vaccines Revenue (US$ Million) and Market Share by Application
    Table 91. J&J(Crucell) Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 92. J&J(Crucell) Recent Development
    Table 93. China National Biotec Corporation Information
    Table 94. China National Biotec Description and Business Overview
    Table 95. China National Biotec Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 96. China National Biotec Vaccines Product
    Table 97. China National Biotec Vaccines Revenue (US$ Million) and Market Share by Product
    Table 98. China National Biotec Vaccines Revenue (US$ Million) and Market Share by Application
    Table 99. China National Biotec Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 100. China National Biotec Recent Development
    Table 101. Tiantan Corporation Information
    Table 102. Tiantan Description and Business Overview
    Table 103. Tiantan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 104. Tiantan Vaccines Product
    Table 105. Tiantan Vaccines Revenue (US$ Million) and Market Share by Product
    Table 106. Tiantan Vaccines Revenue (US$ Million) and Market Share by Application
    Table 107. Tiantan Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 108. Tiantan Recent Development
    Table 109. Hualan Corporation Information
    Table 110. Hualan Description and Business Overview
    Table 111. Hualan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 112. Hualan Vaccines Product
    Table 113. Hualan Vaccines Revenue (US$ Million) and Market Share by Product
    Table 114. Hualan Vaccines Revenue (US$ Million) and Market Share by Application
    Table 115. Hualan Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 116. Hualan Recent Development
    Table 117. Kangtai Corporation Information
    Table 118. Kangtai Description and Business Overview
    Table 119. Kangtai Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 120. Kangtai Vaccines Product
    Table 121. Kangtai Vaccines Revenue (US$ Million) and Market Share by Product
    Table 122. Kangtai Vaccines Revenue (US$ Million) and Market Share by Application
    Table 123. Kangtai Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 124. Kangtai Recent Development
    Table 125. Hissen Corporation Information
    Table 126. Hissen Description and Business Overview
    Table 127. Hissen Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 128. Hissen Vaccines Product
    Table 129. Hissen Vaccines Revenue (US$ Million) and Market Share by Product
    Table 130. Hissen Vaccines Revenue (US$ Million) and Market Share by Application
    Table 131. Hissen Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 132. Hissen Recent Development
    Table 133. Jintan Corporation Information
    Table 134. Jintan Description and Business Overview
    Table 135. Jintan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
    Table 136. Jintan Vaccines Product
    Table 137. Jintan Vaccines Revenue (US$ Million) and Market Share by Product
    Table 138. Jintan Vaccines Revenue (US$ Million) and Market Share by Application
    Table 139. Jintan Vaccines Revenue (US$ Million) and Market Share by Geographic Area
    Table 140. Jintan Recent Development
    Table 141. Global Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 142. Global Vaccines Sales Forecast by Type (2022-2027) & (K Pcs)
    Table 143. Global Vaccines Revenue by Type (2016-2021) & (US$ Million)
    Table 144. Global Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 145. Global Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 146. Global Vaccines Sales Forecast by Application (2022-2027) & (K Pcs)
    Table 147. Global Vaccines Revenue by Application (2016-2021) & (US$ Million)
    Table 148. Global Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 149. North America Vaccines Sales by Country (2016-2021) & (K Pcs)
    Table 150. North America Vaccines Sales by Country (2022-2027) & (K Pcs)
    Table 151. North America Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 152. North America Vaccines Revenue by Country (2022-2027) & (US$ Million)
    Table 153. North America Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 154. North America Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 155. Asia-Pacific Vaccines Sales by Region (2016-2021) & (K Pcs)
    Table 156. Asia-Pacific Vaccines Sales by Region (2022-2027) & (K Pcs)
    Table 157. Asia-Pacific Vaccines Revenue by Region (2016-2027) & (US$ Million)
    Table 158. Asia-Pacific Vaccines Revenue by Region (2022-2027) & (US$ Million)
    Table 159. Asia-Pacific Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 160. Asia-Pacific Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 161. Europe Vaccines Sales by Country (2016-2021) & (K Pcs)
    Table 162. Europe Vaccines Sales by Country (2022-2027) & (K Pcs)
    Table 163. Europe Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 164. Europe Vaccines Revenue by Country (2022-2027) & (US$ Million)
    Table 165. Europe Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 166. Europe Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 167. Latin America Vaccines Sales by Country (2016-2021) & (K Pcs)
    Table 168. Latin America Vaccines Sales by Country (2022-2027) & (K Pcs)
    Table 169. Latin America Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 170. Latin America Vaccines Revenue by Country (2022-2027) & (US$ Million)
    Table 171. Latin America Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 172. Latin America Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 173. Middle East and Africa Vaccines Sales by Country (2016-2021) & (K Pcs)
    Table 174. Middle East and Africa Vaccines Sales by Country (2022-2027) & (K Pcs)
    Table 175. Middle East and Africa Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 176. Middle East and Africa Vaccines Revenue by Country (2022-2027) & (US$ Million)
    Table 177. Middle East and Africa Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 178. Middle East and Africa Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 179. Vaccines Key Raw Materials, Industry Status and Trend
    Table 180. Vaccines Key Raw Materials and Upstream Suppliers
    Table 181. Vaccines Clients Status and Trend
    Table 182. Vaccines Typical Clients
    Table 183. Vaccines Distributors
    Table 184. Key Drivers: Impact Analysis (2022-2027)
    Table 185. Vaccines Market Drivers
    Table 186. Vaccines Market Opportunities
    Table 187. Vaccines Market Challenges
    Table 188. Vaccines Market Restraints
    Table 189. Vaccines Porter’s Five Forces Analysis
    Table 190. Research Programs/Design for This Report
    Table 191. Key Data Information from Secondary Sources
    Table 192. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccines Product Picture
    Figure 2. Global Vaccines Sales Market Share by Type in 2021 & 2027
    Figure 3. Recombinant Vaccines Product Picture
    Figure 4. Viral Vaccines Product Picture
    Figure 5. Polysaccharide Vaccines Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Vaccines Sales Market Share by Application in 2021 & 2027
    Figure 8. Rabies vaccine Examples
    Figure 9. Influenza vaccine Examples
    Figure 10. HPV vaccine Examples
    Figure 11. Hepatitis B Examples
    Figure 12. Hepatitis A Examples
    Figure 13. Leprosy vaccine Examples
    Figure 14. Polio vaccine Examples
    Figure 15. JE vaccine Examples
    Figure 16. Others Examples
    Figure 17. Vaccines Report Years Considered
    Figure 18. Global Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 19. Global Vaccines Market Size 2016-2027 (US$ Million)
    Figure 20. Global Vaccines Sales 2016-2027 (K Units)
    Figure 21. Global Vaccines Market Size Market Share by Region: 2021 Versus 2027
    Figure 22. Global Vaccines Sales Market Share Forecast by Region (2016-2027)
    Figure 23. Global Vaccines Revenue Market Share by Region (2016-2027)
    Figure 24. Global Vaccines Sales Share by Manufacturer in 2020
    Figure 25. Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 26. Global Vaccines Sales Market Share Forecast by Type (2016-2027)
    Figure 27. Global Vaccines Revenue Market Share Forecast by Type (2016-2027)
    Figure 28. Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 29. Global Vaccines Sales Market Share Forecast by Application (2016-2027)
    Figure 30. Global Vaccines Revenue Market Share Forecast by Application (2016-2027)
    Figure 31. Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 32. North America Vaccines Revenue 2016-2027 (US$ Million)
    Figure 33. North America Vaccines Sales Market Share by Type (2016-2021)
    Figure 34. North America Vaccines Sales Market Share by Application (2016-2021)
    Figure 35. Asia-Pacific Vaccines Revenue 2016-2027 (US$ Million)
    Figure 36. Asia-Pacific Vaccines Sales Market Share by Region (2016-2027)
    Figure 37. Asia-Pacific Vaccines Revenue Market Share by Region (2016-2027)
    Figure 38. Asia-Pacific Vaccines Sales Market Share by Type (2016-2021)
    Figure 39. Asia-Pacific Vaccines Sales Market Share by Application (2016-2021)
    Figure 40. Europe Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 41. Europe Vaccines Sales Market Share by Country (2016-2027)
    Figure 42. Europe Vaccines Revenue Market Share by Country (2016-2027)
    Figure 43. Europe Vaccines Sales Market Share by Type (2016-2021)
    Figure 44. Europe Vaccines Sales Market Share by Application (2016-2021)
    Figure 45. Latin America Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 46. Latin America Vaccines Sales Market Share by Country (2016-2027)
    Figure 47. Latin America Vaccines Revenue Market Share by Country (2016-2021)
    Figure 48. Latin America Vaccines Sales Market Share by Type (2016-2021)
    Figure 49. Latin America Vaccines Sales Market Share by Application (2016-2021)
    Figure 50. Middle East and Africa Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 51. Middle East and Africa Vaccines Sales Market Share by Country (2016-2027)
    Figure 52. Middle East and Africa Vaccines Revenue Market Share by Country (2016-2027)
    Figure 53. Middle East and Africa Vaccines Sales Market Share by Type (2016-2021)
    Figure 54. Middle East and Africa Vaccines Sales Market Share by Application (2016-2021)
    Figure 55. Vaccines Supply Chain (Upstream and Downstream Market)
    Figure 56. Global Production Market Share of Vaccines Raw Materials by Region in 2020
    Figure 57. Vaccines Distribution Channels
    Figure 58. Global Vaccines Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 59. Global Vaccines Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 60. Porter's Five Forces Analysis
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows multiple user to access the PDF.

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global Vaccine Temperature Monitoring System Market Insights Forecast to 2028
Global Vaccine Temperature Monitoring System Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-10F7540
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nelfinavir Market Insights Forecast to 2028
Global Nelfinavir Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-25I7469
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Vancomycin Market Insights and Forecast to 2028
Global Vancomycin Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-20N7760
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Hepatitis B Human Immunoglobulin Market Insights and Forecast to 2028
Global Hepatitis B Human Immunoglobulin Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-22V7718
Tue May 03 00:00:00 UTC 2022

Add to Cart